Realty Income (NYSE: O) is expanding into Mexico, launching a $1.5 billion joint venture, and locking in long-term cash flow. With 98.7% occupancy and a 5% monthly dividend, this defensive REIT may be built for steady upside in 2026. The real question is whether today’s price still offers an opportunity before the next leg higher. … Read more
D-Wave Quantum (NYSE: QBTS) just landed a Fortune 100 contract that could transform its entire business model. Recurring revenue could unlock massive upside, but insider selling and a 227x valuation raise serious questions. Is this the early stage of a 10x opportunity, or a high-risk speculative bet investors are underestimating? Stock prices used were the … Read more
Owens Corning (NYSE: OC) is trading at just 10x earnings while generating strong cash flow and maintaining a low payout ratio. With analysts targeting up to 40% upside and durable roofing demand, this overlooked stock could reward patient investors willing to wait for a housing recovery. Stock prices used were the market prices of Feb. … Read more
Super Micro Computer (NASDAQ: SMCI) just posted triple-digit revenue growth, confirming massive AI demand. But shrinking margins are the real story. If profitability stabilizes and execution stays clean, this stock could warrant a dramatic rerating. If not, expectations may reset fast. Stock prices used were the market prices of Feb. 13, 2026. The video was … Read more
Exxon Mobil (NYSE: XOM) may not be flashy, but it is built to endure. With decades of low-cost oil assets, rising production, and 43 straight years of dividend growth, this energy giant could offer stability amid market volatility. The question is whether today’s valuation still leaves room for meaningful upside. Stock prices used were the … Read more
Pfizer (NYSE: PFE) is trading at just 9 times earnings with a 6% yield, and analysts see up to 30% upside. Is the market underestimating its cash flow, dividend strength, and global scale? I break down the numbers and reveal why this defensive giant could quietly surprise investors in 2026. Stock prices used were the … Read more
Amcor (NYSE: AMCR) may look boring, but this 5.3% yielding packaging giant just delivered a major profit jump after its Berry merger. I break down why steady cash flow, global scale, and merger synergies could quietly drive upside while paying investors generous income along the way. Stock prices used were the market prices of Feb. … Read more
AMD (NASDAQ: AMD) just delivered explosive earnings growth, yet the stock plunged nearly 20%. I break down why this sell-off could be a rare opportunity as AI catalysts like OpenAI, MI450, and EPYC expansion set the stage for a powerful multi-year earnings surge. Stock prices used were the market prices of Feb. 16, 2026. The … Read more
Eli Lilly (NYSE: LLY) is entering 2026 with explosive revenue growth, strong momentum in its powerful obesity drug, and multiple Phase 3 catalysts. With guidance pointing toward $83 billion in revenue and analysts targeting major upside, this healthcare giant could still have significant room to run. Stock prices used were the market prices of Feb. … Read more
Rigetti Computing (NASDAQ: RGTI) has surged more than 1,300%, yet revenue remains tiny and losses are mounting. I break down what the company has actually built, the real financial risks, and what must happen for quantum relevance by 2030. Stock prices used were the market prices of Feb. 9, 2026. The video was published on … Read more
You Found Me :)
Now Let's Grow Your Wealth
Learn to invest like the pros—even if you're just starting.
